本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Organogenesis Holdings Inc

5.01
-0.2400-4.57%
盘后5.020.0100+0.20%19:59 EDT
成交量:103.93万
成交额:531.73万
市值:6.35亿
市盈率:-501.00
高:5.40
开:5.26
低:4.99
收:5.25
数据加载中...

公司资料

公司名字:
Organogenesis Holdings Inc
交易所:
NASDAQ
成立时间:
- -
员工人数:
869
公司地址:
85 Dan Road,Canton,Massachusetts,United States
邮编:
02021
电话:
传真:
- -
简介:
Organogenesis Holdings Inc.是特拉华州的一家公司。该公司是一家领先的再生医学公司,在先进的伤口护理和外科生物制剂(包括骨科和脊柱)中提供生物活性和非细胞生物材料产品组合。Organogenesis全面的产品组合旨在治疗各种有修复和再生需求的患者。

董事

名称
职位
Gary S. Gillheeney, Sr.
Director, Chairman of the Board, President and Chief Executive Officer
Arthur S. Leibowitz
Director, Lead Independent Director
Alan A. Ades
Director
David Erani
Director
Gilberto Quintero
Director
Glenn H. Nussdorf
Director
Jon Giacomin
Director
Michael J. Driscoll
Director
Michele Korfin
Director
Prathyusha Duraibabu
Director
Robert Ades
Director

股东

名称
职位
Gary S. Gillheeney, Sr.
Director, Chairman of the Board, President and Chief Executive Officer
Patrick Bilbo
Chief Operating Officer
David C. Francisco
Chief Financial Officer
Antonio S. Montecalvo
Vice President, Health Policy
Brian Grow
Chief Commercial Officer
Lori Freedman
Chief Administrative and Legal Officer